Source: Eur Respir J 2011; 38: 649-656
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Ling D.I., Pai M., Davids V., Brunet L., Lenders L., Meldau R., Calligaro G., Allwood B., van Zyl-Smit R., Peter J., Bateman E., Dawson R., Dheda K.. Are interferon- gamma release assays useful for diagnosing active tuberculosis in a high-burden setting?. Eur Respir J 2011; 38: 649-656

Member's Comments

No comment yet.

Related content which might interest you: New immunologic tools for the diagnosis and therapy of tuberculosis Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005 Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection Source: Eur Respir J 2006; 28: 24-30 Year: 2006 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2011; 39: 163-171 Year: 2012 Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2012; 39: 163-171 Year: 2012 Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients Source: Eur Respir J 2006; 28: 31-34 Year: 2006 Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB Source: Eur Respir Mon 2012; 58: 1-13 Year: 2012 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis Source: Eur Respir J 2007; 30: 722-728 Year: 2007 Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-γ assay Source: Eur Respir J 2007; 29: 1212-1216 Year: 2007 Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1238-1239 Year: 2011 A T-cell-based assay for rapid diagnosis of difficult cases of tuberculosis (TB): smear negative pulmonary and extra-pulmonary TB Source: Eur Respir J 2005; 26: Suppl. 49, 240s Year: 2005 Glycopeptidolipids for evaluating the role of non-tuberculous mycobacteria in latent tuberculosis infection diagnosis Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009 Contribution of the T-SPOT.TB assay for detection of latent tuberculous infection (LTBI) in contact tracing procedures Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection Year: 2006 Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis Source: Eur Respir J 2011; 37: 376 Year: 2011